Am J Cardiol

1. KOBAYASHI T, Mahfoud F
   Lessons From Unusual Cases.
   Am J Cardiol. 2025;257:84-87.
   

   >> Share

   
   
2. KUNKEL KJ, Townsend RR, Kandzari DE
   Renal Denervation: Procedural Aspects and Efficacy.
   Am J Cardiol. 2025;257:7-11.
   

   >> Share

   
   

   
   Am J Hypertens

3. PADWAL RS, Dorsch M, Tobe S, Ringrose J, et al
   The Role of Renal Denervation in the Treatment of Hypertension in Canada: A Case-Based Discussion from the Canadian Hypertension Specialists Society.
   Am J Hypertens. 2025 Dec 6:hpaf236. doi: 10.1093.
   

   >> Share

   
   
4. ZHANG M, Li P, Sheng Y
   Innovative device-based treatments for hypertension.
   Am J Hypertens. 2025 Dec 4:hpaf235. doi: 10.1093.
   

   >> Share

   
   

   
   Am J Kidney Dis

5. MALEPATI D, Drawz PE
   Selecting Antihypertensive Medications for Kidney Transplant Recipients: Flying Blind.
   Am J Kidney Dis. 2025 Dec 2:S0272-6386(25)01166.
   

   >> Share

   
   

   
   BMC Neurol

6. NEYAZI A, Neyazi M, Neyazi M, Razaqi N, et al
   Prevalence and types of headache, sleep disturbances and hypertension among non-psychotic patients.
   BMC Neurol. 2025 Dec 9. doi: 10.1186/s12883-025-04579.
   

   >> Share

   
   

   
   Circ Heart Fail

7. AGUADO B, Ruffenach G, Lacoste-Palasset T, Gorlach A, et al
   Use of SGLT2 (Sodium-Glucose Cotransporter 2) Inhibitors in Pulmonary Hypertension.
   Circ Heart Fail. 2025 Dec 5:e013481. doi: 10.1161/CIRCHEARTFAILURE.125.013481.
   

   >> Share

   
   

   
   Circulation

8. CAI A, Bayes-Genis A, Ryan J, Feng Y, et al
   Heart Stress and Blood Pressure Management in Older Adults: Post Hoc Analysis of the ASPREE Trial.
   Circulation. 2025 Oct 22. doi: 10.1161/CIRCULATIONAHA.125.076263.
   

   >> Share

   
   
9. LI F, Poudel B, Andrade-Silva M, Wu J, et al
   Cell-Specific Inducible Human APOL1 Risk Variant Expression in Mice Causes Hypertension and Renal Damage.
   Circulation. 2025 Dec 11:10.1161/CIRCULATIONAHA.124.071351.
   

   >> Share

   
   

   
   Clin Exp Hypertens

10. LUO R, Huang Y, Leng Y, Liao W, et al
    Blood pressure variability: From predictive marker to intervention target-breaking the vicious cycle of hypertensive target organ damage.
    Clin Exp Hypertens. 2025;47:2601054.
    

    >> Share

    
    
11. ZHENG J, Lu C
    Metabolic dysfunction-associated fatty liver disease and risk of hypertension in young adults: A cross-sectional study mediated by inflammatory markers.
    Clin Exp Hypertens. 2025;47:2597852.
    

    >> Share

    
    
12. WEI X, Li L, Zhao G, Luan Y, et al
    Hypertension and Alzheimer's disease: Pathological interplay, comorbidity risks, and new strategies for synergistic management.
    Clin Exp Hypertens. 2025;47:2595154.
    

    >> Share

    
    

    
    Eur Heart J

13. BIDEL Z, Nazarzadeh M, Canoy D, McEvoy JW, et al
    Blood pressure lowering in isolated diastolic hypertension and cardiovascular risk: an individual patient data meta-analysis.
    Eur Heart J. 2025 Dec 12:ehaf962. doi: 10.1093.
    

    >> Share

    
    
14. VERDECCHIA P, Angeli F, Reboldi G
    Should systolic pressure be lowered in isolated diastolic hypertension?
    Eur Heart J. 2025 Dec 12:ehaf950. doi: 10.1093.
    

    >> Share

    
    

    
    Hypertension

15. ZHONG C, Wang M, Liu D, Wei Y, et al
    Antihypertensive Treatments After Acute Ischemic Stroke: to Continue or Not?
    Hypertension. 2025 Dec 5. doi: 10.1161/HYPERTENSIONAHA.125.25575.
    

    >> Share

    
    
16. ROSSIGNOL P, Clozel M, Dreier RF, Flack JM, et al
    Aprocitentan in Patients With Chronic Kidney Disease and Resistant Hypertension.
    Hypertension. 2025 Dec 9. doi: 10.1161/HYPERTENSIONAHA.125.25563.
    

    >> Share

    
    
17. SEMENOVYKH K, Pravenec M, Vaneckova I, Houdek P, et al
    Tert Deletion Impairs Circadian Regulation of Blood Pressure in Male Spontaneously Hypertensive Rats.
    Hypertension. 2025 Dec 10. doi: 10.1161/HYPERTENSIONAHA.125.25510.
    

    >> Share

    
    
18. VUORI M, Ruuskanen MO, Jousilahti P, Salomaa V, et al
    Value of Multiomics Over Clinical Risk Factors in Hypertension Prediction.
    Hypertension. 2025 Dec 11. doi: 10.1161/HYPERTENSIONAHA.125.25358.
    

    >> Share

    
    
19. RAUSEO E, Salih AM, Cooper J, Abdulkareem M, et al
    Clinical Phenotypes in Hypertension: A Data-Driven Approach to Risk Stratification.
    Hypertension. 2025 Dec 11. doi: 10.1161/HYPERTENSIONAHA.125.25187.
    

    >> Share

    
    
20. BYRD JB, Batlle D
    Time to Measure Angiotensin II When Screening for Primary Aldosteronism in the Evaluation of Secondary Hypertension.
    Hypertension. 2025 Dec 11. doi: 10.1161/HYPERTENSIONAHA.125.25990.
    

    >> Share

    
    

    
    J Am Coll Cardiol

21. DODSON JA, Adhikari S, Schoenthaler AM, Shimbo D, et al
    Behavioral Economics and Medication Adherence for Hypertension: A Randomized Clinical Trial.
    J Am Coll Cardiol. 2025 Nov 18:S0735-1097(25)10073.
    

    >> Share

    
    

    
    J Hum Hypertens

22. OUYANG D, Cao W, Shen Y, Chen L, et al
    Trends and risk factors of hypertension in US Children and Adolescents, 1999-2023.
    J Hum Hypertens. 2025 Dec 5. doi: 10.1038/s41371-025-01102.
    

    >> Share

    
    
23. DUUS CL, Nielsen SF, Lyksholm TZ, Mose FH, et al
    Sodium reduction is the key ingredient in dietary treatment of hypertension - a randomized controlled trial on sodium, potassium and nitrate.
    J Hum Hypertens. 2025 Dec 4. doi: 10.1038/s41371-025-01104.
    

    >> Share

    
    
24. SUKSIRIWORABOOT T, Yacharad A, Kositanurit W, Vorasettakarnkij Y, et al
    Prevalence of apparent treatment-resistant hypertension and screening rates for primary aldosteronism in an asian ambulatory care setting.
    J Hum Hypertens. 2025 Dec 4. doi: 10.1038/s41371-025-01105.
    

    >> Share

    
    
25. ERNST ME, Sheets KM, Webb KL, Fravel MA, et al
    Late-life, visit-to-visit blood pressure variability and its association with sex-specific long-term cognitive outcomes.
    J Hum Hypertens. 2025;39:831-840.
    

    >> Share

    
    
26. ZACHWYC J, Sharman JE, Kosowski W, Woznicka AK, et al
    Exaggerated blood pressure response to submaximal exercise and cardiac target organ damage: importance of fitness.
    J Hum Hypertens. 2025;39:849-858.
    

    >> Share

    
    

    
    J Neurosurg

27. PROKOP K, Opechowska A, Sawicki K, Zarzecki M, et al
    Beyond idiopathic intracranial hypertension: optic nerve decompression for vision preservation in cerebrospinal fluid flow disorders. A mechanism-based approach.
    J Neurosurg. 2025 Dec 5:1-11. doi: 10.3171/2025.8.JNS251211.
    

    >> Share

    
    

    
    JAMA

28. PANT S
    Chronic Pain Linked to Hypertension.
    JAMA. 2025 Dec 12. doi: 10.1001/jama.2025.20022.
    

    >> Share

    
    
29. ANDERER S
    Hypertension Among Children Has Increased Significantly.
    JAMA. 2025 Dec 5. doi: 10.1001/jama.2025.20012.
    

    >> Share

    
    

    
    PLoS Med

30. WANG LT, Chien WC, Ma KS, Chung CH, et al
    Association of hydralazine use with risk of hematologic neoplasms in patients with hypertension: A nationwide population-based cohort study in Taiwan.
    PLoS Med. 2025;22:e1004646.
    

    >> Share

    
    

    
    PLoS One

31. BHANDARI S, Pokharel PK, Maharjan A, Rajbanshi M, et al
    Prehypertension and its associated factors among government employees in Tilottama Municipality of Rupandehi District, Nepal.
    PLoS One. 2025;20:e0338625.
    

    >> Share

    
    
32. SHARIF AB, Chowdhury SSA, Hossain MZ, Hossain MA, et al
    Prevalence and factors associated with adverse birth outcomes among women with chronic hypertension in Rangpur: A multi-center cross-sectional study.
    PLoS One. 2025;20:e0337526.
    

    >> Share

    
    
33. OSTERLIND J, Birnefeld J, Birnefeld E, Hultin M, et al
    Study protocol: MRI-based assessment of cerebral blood flow under pharmacologically elevated blood pressure in patients under general anesthesia, and in sedated ICU patients with aneurysmal subarachnoid hemorrhage.
    PLoS One. 2025;20:e0338688.
    

    >> Share

    
    
34. PITTMAN MC, Perez AD, Tanni KA, Sanderson KR, et al
    Dosing trajectories of antihypertensive agents among preterm neonates: A retrospective, cross-sectional analysis.
    PLoS One. 2025;20:e0336994.
    

    >> Share

    
    
35. ZHENG C, Liu Y, Zeng S, Xie S, et al
    Association between average triglyceride glucose-body mass index and risk of hypertension in middle-aged and elderly Chinese: A study based on Chinese CHARLS cohort data.
    PLoS One. 2025;20:e0337710.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share